GA101-miniCHOP

obinutuzumab-based regimen? (GA101 is obinutuzumab)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GA101-miniCHOP, covering 2020-11-05 to 2020-11-05. Get the full timeline:

Most recent: Clinical Trial Update: GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma [Phase 2]

See pricing